GEO Investing

In our 7/15/13 email to GeoInvesting premium members we discussed the K-V Pharmaceuticals (OOTC:KVPHQ) Chapter 11 bankruptcy case.  Shares were trading around $0.60 at the time of our email.  Specifically, we questioned why shares have been strong in recent trading […]

Polydex Pharmaceuticals Limited, through its subsidiaries, engages in the development, manufacture, and marketing of biotechnology-based products for the human pharmaceutical market.  It is also involved with manufacture of bulk pharmaceutical intermediates for the veterinary pharmaceutical industry worldwide. It primarily offers […]

In keeping with the recent theme of following software related companies, the GeoTeam has begun to track B-Scada, Inc. (PINK: MOBS). We could not help but notice that there will be a software-as-a-service (SaaS) angle intrinsic to the operations of […]

Navidea Biopharmaceuticals (NAVB) is one of the most attractive short opportunities we have seen in some time. The company resubmitted its long-awaited drug candidate, Lymphoseek, to the FDA on October 31, 2012. Any “emotional” pop in NAVB’s share price that […]